HSBC Holdings’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $815K | Buy |
25,792
+3,989
| +18% | +$126K | ﹤0.01% | 1477 |
|
|
2025
Q1 | $714K | Buy |
21,803
+1,402
| +7% | +$45.9K | ﹤0.01% | 1493 |
|
|
2024
Q4 | $701K | Buy |
20,401
+2,424
| +13% | +$83.3K | ﹤0.01% | 1607 |
|
|
2024
Q3 | $715K | Sell |
17,977
-5,823
| -24% | -$232K | ﹤0.01% | 1501 |
|
|
2024
Q2 | $731K | Buy |
23,800
+16,076
| +208% | +$494K | ﹤0.01% | 1486 |
|
|
2024
Q1 | $259K | Buy |
+7,724
| New | +$259K | ﹤0.01% | 2132 |
|
|
2023
Q4 | – | Sell |
-10,026
| Closed | -$331K | – | 2278 |
|
|
2023
Q3 | $331K | Buy |
+10,026
| New | +$331K | ﹤0.01% | 1699 |
|
|
2023
Q1 | – | Sell |
-9,783
| Closed | -$530K | – | 2341 |
|
|
2022
Q4 | $530K | Buy |
9,783
+4,227
| +76% | +$229K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $247K | Buy |
+5,556
| New | +$247K | ﹤0.01% | 2089 |
|
|
2022
Q2 | – | Sell |
-7,290
| Closed | -$363K | – | 2865 |
|
|
2022
Q1 | $363K | Buy |
+7,290
| New | +$363K | ﹤0.01% | 2275 |
|